OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study
Luca Masotti, Giancarlo Landini, Grazia Panigada, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108709-108709
Open Access | Times Cited: 5

Showing 5 citing articles:

Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab
Antonio Ramón, Marta Zaragozá, Ana María Torres, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4729-4729
Open Access | Times Cited: 6

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study
Vasiliki Georgakopoulou, Dimitrios Basoulis, Pantazis Voutsinas, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 6

COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study
Carmen Infante-Domínguez, Sonsoles Salto‐Alejandre, Rocío Álvarez‐Marín, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Risk and extent of intracranial haemorrhage in patients with SARS-CoV-2 infection admitted to intensive care unit
George Simion, Sergio Calero Martinez, Katharina Klumbies, et al.
Research Square (Research Square) (2023)
Open Access

Nimotuzumab in the Treatment of Severe Pneumonia due to COVID-19. Presentation of a Case
Pedroso RM
Pharmaceutical Drug Regulatory Affairs Journal (2023) Vol. 6, Iss. 1, pp. 1-5
Open Access

Page 1

Scroll to top